title: Reflux esophagitis: an update.
abstract: In recent years, much has been learned about the pathogenesis, diagnosis, and treatment of gastroesophageal (GE) reflux disease. Mucosal resistance, gastric contents, esophageal acid clearance, gastric emptying, and incompetency of the lower esophageal sphincter are contributing factors to GE reflux. Use of the various diagnostic tests and an overview of current therapy are summarized.
authors.forename: J L
authors.initials: JL
authors.lastname: Nelson
authors.forename: D O
authors.initials: DO
authors.lastname: Castell
mesh_terms: D000464:Alginates / Q000627:therapeutic use; D000863:Antacids / Q000627:therapeutic use; D001466:Barium Sulfate; D018723:Bethanechol; D001626:Bethanechol Compounds / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004942:Esophagitis, Peptic / Q000175:diagnosis / Q000209:etiology / Q000601:surgery / Q000628:therapy; D004945:Esophagoscopy; D004947:Esophagus / Q000000981:diagnostic imaging / Q000473:pathology; D005746:Gastric Emptying; D020723:Glucuronic Acid; D006603:Hexuronic Acids; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008787:Metoclopramide / Q000627:therapeutic use; D011859:Radiography; D013270:Stomach / Q000000981:diagnostic imaging
chemical_list: D000464:Alginates; D000863:Antacids; D001626:Bethanechol Compounds; D006603:Hexuronic Acids; D018723:Bethanechol; D001466:Barium Sulfate; D020723:Glucuronic Acid; D008787:Metoclopramide